Clinical trial

Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients…

NCT00442364 · Boston Scientific Corporation, Industry · Completed

Key facts

NCT number NCT00442364
Title Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
Official title An Open Label Multicenter Safety Study of the Varisolve® Procedure for the Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
Acronym MRI
Lead sponsor Boston Scientific Corporation, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Varicose Veins
Intervention type Drug, Procedure
Interventions Polidocanol (1%) Microfoam (Varisolve), Endovenous Microfoam Occlusion
Enrollment 60
Start date Mar 1, 2007
Primary completion Jun 1, 2008
Completion Aug 1, 2009
First posted Mar 1, 2007
Last update posted Apr 21, 2021
Countries United States

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies